Nomograms and Medicine

European Urology

Volumn 50, Issue 5, 2006, Pages 884-886

  Bianco Jr , Fernando J ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER THERAPY; EDITORIAL; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; NOMOGRAM; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION;

HUMANS; MALE; MEDICINE; NOMOGRAMS; PROSTATIC NEOPLASMS;

EID: 33749338093     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.07.043     Document Type: Editorial

References (10)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Edwards B.K., Brown M.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 (2005) 1407-1427
3. Miller A.B., Madalinska J.B., Church T., et al. Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial. Eur J Cancer 37 (2001) 2154-2160
4. Lambert J.H. Pyrometrie; oder, Vom Maasse des Feuers und der Wärme mit acht Kupfertafeln (1779), Bey Haude & Spener, Berlin pp. 424-88
5. Henderson L.J. Blood: a study in general physiology Vol. 3 (1928), Yale University Press, New Haven, CT p. 148, Fig. 141
6. Kattan M.W., Eastham J.A., Stapleton A.M., Wheeler T.M., and Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
7. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499-1507
8. Chun F.K.-H., Karakiewicz P.I., Briganti A., et al. Prostate cancer nomograms: an update. Eur Urol. 50 (2006) 914-926
9. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
10. Graefen M., Haese A., Pichlmeier U., et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol 165 (2001) 857-863